Company intelligence / Profile preview

Sarah Cannon

Nashville, Tennessee, United Statessarahcannon.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Sarah Cannon leads one of the world’s largest community-based oncology research networks. It has conducted over 400 first-in-human drug development studies and supports more than 500 unique clinical trial options annually. Its network treats over 130,000 new cancer patients each year across the US and UK. The organization has contributed to the approval or development of numerous cancer therapies since its founding in the early '90s. It also offers advanced personalized medicine through molecular profiling to match patients with targeted therapies.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyCell therapy (including CAR-T and stem cell transplants)Radiation therapyChemotherapyPersonalized medicine/molecular profiling
Industry: Academic Hospital/University/Research

Partnerships

Joint venture with former US Oncology Research for expanded national reach in clinical trialsCollaborates with pharmaceutical sponsors for drug development studies

Beyond the preview

Go deeper on Sarah Cannon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarah Cannon.

Explore the full profile